Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

NCT03680417 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Immunogenicity

Interventions

BIOLOGICAL: Measles-Rubella (MR) Vaccine

Sponsor

PT Bio Farma